HIVACAT

HIVACAT

HIVACAT HIVACAT is an HIV vaccine research and development program undertaken by an unprecedented private-public consortium that puts Spain and Catalonia on the front line of international research in the field. The program is developed by two of the most important...
IHIVARNA

IHIVARNA

Therapeutic TriMix / mRNA based Vaccine in Chronic HIV-1 Infected Patients Receiving Antiretroviral Therapy The iHIVARNA project is an immunogen-focused research project that brings together the expertise of a number of European groups in dendritic cells targeting,...
INBIOMEDVISION

INBIOMEDVISION

INBIOMEDVISION INBIOMEDvision was a Coordination and Support Action (CSA) funded by the European Commission 7th Framework Programme of ICT under the Virtual Physiological Human (VPH) flagship. The 2.5 year project ran from 2011 to 2013 and had a total budget of 1.1M€....
Neogenius Pharma

Neogenius Pharma

Neogenius Pharma The NEOGENIUS Project, set up on the basis of a strategic alliance between three pharmaceutical companies (Almirall, Esteve and Draconis) and a biotech company (Proteomika), received a 7.6 million euros grant from the CENIT programme in 2009. The...
NEOVANC

NEOVANC

NeoVanc – Treatment of late onset bacterial sepsis caused by Vancomycin susceptible bacteria in neonates and infants aged under three months NeoVanc is a project funded by the European Commission under the Seventh Framework Programme, involving 12 partners from...